Adial Pharmaceuticals Inc. (ADIL) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Adial Pharmaceuticals Inc...

    NASDAQ: ADIL · Real-Time Price · USD
    0.47
    -0.14 (-22.46%)
    At close: Jul 30, 2025, 3:59 PM

    Adial Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -13.2M -7M -12.73M -19.42M
    Depreciation & Amortization
    		 565.00 564.00 60.5K 55.11K
    Stock-Based Compensation
    		 796.83K 1.82M 3.37M 4.24M
    Other Working Capital
    		 215.13K -634.79K -1.48M 1.82M
    Other Non-Cash Items
    		 5.09M 988.72K -522K 1.81M
    Deferred Income Tax
    		 n/a -1.91M -502 -94.08K
    Change in Working Capital
    		 386.14K -794.21K -1.37M 1.46M
    Operating Cash Flow
    		 -6.92M -6.81M -11.19M -11.95M
    Capital Expenditures
    		 n/a 6.81M n/a -64.61K
    Cash Acquisitions
    		 n/a n/a n/a 30.59K
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a 1.5M n/a -0.00
    Investing Cash Flow
    		 n/a 1.5M n/a -34.02K
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a -1.66K n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 3.82M 4.13M 1.86K 1.89M
    Financial Cash Flow
    		 7.85M 4.13M 9.13M 13.64M
    Net Cash Flow
    		 923.44K -1.17M -2.06M 1.66M
    Free Cash Flow
    		 -6.92M n/a -11.19M -12.01M

    Add to Watchlist